Navigation Links
Mediware Completes Acquisition of Integrated Marketing Solutions
Date:10/31/2007

Acquisition enhances focus on Blood and Plasma Donor Centers

LENEXA, Kan., Oct. 31 /PRNewswire-FirstCall/ -- Mediware Information Systems, Inc., (Nasdaq: MEDW), a provider of ClosedLoop(TM) clinical systems for blood and medication management, announced that the Company has completed the acquisition of substantially all of the assets of Integrated Marketing Solutions (IMS). IMS is a provider of software products and services that enable blood and plasma donation centers to improve donor relationship management with powerful web based tools. In the transaction that was announced on October 16, 2007, Mediware's purchase agreement includes a cash payment of approximately $5.2M with an additional earn out opportunity based on operational performance.

"We are very excited to have this transaction complete," said Kelly Mann, Mediware's President and Chief Executive Officer. "IMS has an exceptional reputation within the industry -- one that is built from its experienced staff, powerful technology and responsive customer care."

Mann continued, "The addition of IMS enhances Mediware's vision for ClosedLoop(TM) management of the blood supply and enables our mutual clients with increased capabilities. It also provides our clients and investors a clear indication that our strategy is to invest in our capabilities and deliver growth."

The IMS software and services address the competitive nature of the blood supply market by enabling blood and plasma collection facilities with automated and online software to better manage relationships with donors, staff and hospitals.

"The IMS products create a logical interface with our existing technology," said Mann. "The integration of IMS's relationship portals, with the clinical management capabilities provided in LifeTrak, will provide end-to-end donor center support and a ClosedLoop environment that streamlines donor center efficiency."

The IMS product line includes the following products that can be licensed individually on a contract basis:

-- RecruitAssist: personalized online environment allowing blood centers

to manage their recruitment efforts and donors to view drive schedules,

schedule appointments, and review their donation histories.

-- CallAssist: tele-recruiting and Donor Relationship Management (DRM)

product that enables telerecruiting staff with all relevant donor

information including contact data, donation histories, loyalty program

status, mobile drive data and web activity.

-- OrderAssist: online supply and inventory manager that electronically

processes orders and tracks delivery status for blood centers and

hospitals.

-- QualityAssist: an online customer service environment facilitating

interaction and communication between donors and blood center staff.

-- CoordinatorAssist: loyalty-driven online software to help blood drive

coordinators plan and manage events at their companies or for their

organizations.

-- DriveAssist: online automated systems to help schedule, promote and

manage mobile blood drives.

-- SalesAssist: online sales force automation software to manage sales

activities, increase sales effectiveness and monitor business

performance.

Mediware has long been a leader in the clinical systems supporting donor centers and the Company's LifeTrak(R) product supports more than 65 facilities. LifeTrak, which includes LifeTrak Donor, LifeTrak Lab and LifeTrak Distribution, is 510(K) cleared as a medical device.

About Mediware

Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at http://www.mediware.com.

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.


'/>"/>
SOURCE Mediware Information Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. iGATE Completes Phase I Testing Of Meningitis Vaccine
2. Delhi Hospital Completes 100 Liver Transplants
3. Roche Completes Acquisition of BioVeris
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
6. NHS financial crisis may lead to roll back of flexi-work scheme and private acquisition
7. Smoking Increases Risk of HIV Acquisition
8. Circassia Announces Acquisition of Organ Transplant Anti-Rejection Technology
9. Integrated Disease Surveillance Project Soon In The Country
10. Integrated Child Development Scheme
11. Mumbai to Have Integrated Trauma Care Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... Angeles, California (PRWEB) , ... May 26, 2017 , ... ... senior citizens who visit a doctor for colds or respiratory issues that are not ... that excessive time pressure on doctors may be largely responsible for the problem both ...
(Date:5/27/2017)... ... , ... Most us are familiar with the sound of occasional popping joints ... Initiative shows that certain people who experience consistent joint popping, grating and grinding ... the opportunity to treat patients before the problem becomes pronounced, potentially hedging off more ...
(Date:5/26/2017)... ... May 26, 2017 , ... The ... educational seminar to focus on current legislative activity and the latest regulatory concerns ... 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. 11, at ...
(Date:5/26/2017)... ... 2017 , ... Boar’s Head Brand®, one of the nation’s ... entertaining that are sure to satisfy your guests’ flavor cravings, while adding delicious ... featured in these refreshingly balanced recipes are packed with flavor, creating the perfect ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Yisrayl Hawkins, ... new publication this week that is focusing on the Peace Agreements being discussed by ... Middle East sprint in a race to try to speed up peace talks in ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... May 22, 2017  As the specialty pharmacy ... continue to make the revolutionary shift from volume-based ... for ensuring positive patient outcomes and shaping the ... shifting focus away from clinical trials and toward ... long-term specialty drug therapy utilization in precise patient ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
Breaking Medicine Technology: